HLX affects cell cycle and proliferation in AML cells via the JAK/STAT signaling pathway

Abstract

Acute myelogenous leukemia (AML) is a class of malignant tumors derived from hematopoietic stem or progenitor cells. The H2.0-like homeobox gene (HLX) encodes transcription factors that function in promoting normal hematopoietic cell proliferation and tumor immunity. The present study analyzed the effect of downregulating the HLX on cell cycle distribution and cell proliferation in AML. Moreover, the current study detected changes in the expression of genes and proteins in the Janus kinase (JAK)/STAT signaling pathway to investigate the mechanism of the action of HLX in tumor immunity in AML. HLX expression in AML cell lines was silenced using small interfering siRNA, and MTS/PMS-assay colorimetric assays were used to assess the effect of knockdown of HLX on AML cell proliferation. Flow cytometry was used to analyze changes in cell cycle distribution, while reverse transcription-quantitative PCR and western blotting were used to detect changes in the expression levels of key components of the JAK/STAT signaling pathway, such as p21-activated kinase 1 (PAK1), neuropilin 1 (NRP1), B-cell translocation gene 1 (BTG1) and STAT5. It was found that HLX was differentially expressed in AML cell lines of various subtypes, and HLX expression was higher in the AML/M3 subtype NB4 cell line compared with the control group. Knockdown of HLX in NB4 cells significantly inhibited cell proliferation and arrested cells in the G 0 /G 1 phase. Moreover, STAT5 protein expression, as well as NRP1 and PAK1 expression levels were downregulated, while BTG1 expression was upregulated when HLX was knocked out by siRNA. Collectively, the results suggested that downregulation of HLX may cause G 0 /G 1 phase arrest and inhibit the proliferation of AML cells by activating the JAK/STAT signaling pathway.

Cysteine- and glycine-rich protein 1 predicts prognosis and therapy response in patients with acute myeloid leukemia

“…HIF signaling has been implicated in myeloid cell survival, and PI3K/Akt is known to induce HIF-1 transcription [38]. The signaling pathway JAK/STAT plays a critical role in the development and progression of AML [39].…”

The Potential Dual Role of H2.0-like Homeobox in the Tumorgenesis and Development of Colorectal Cancer and Its Prognostic Value

“…In addition, the inhibition of HLX expression could reduce the proliferation and clonogenicity of leukemia cells and prolong the survival rate [ 24 ]. Zhu et al have indicated that low HLX expression could reduce the proliferation of acute myelogenous leukemia cells by regulating the JAK/STAT signaling pathway [ 25 ]. This evidence suggested that HLX downregulation might be involved in the progression of some tumors.…”

Curcumol may alleviate psoriasis-like inflammation by inhibiting keratinocyte proliferation and inflammatory gene expression via JAK1/STAT3 signaling

“…The transmission process of this signaling pathway is mainly composed of three components: tyrosine kinase associated receptor, Janus kinase and signal transducer and activator of transcription [ 12 ]. This pathway is involved in many important biological processes such as cell proliferation, differentiation, apoptosis, and immune regulation [ 13 ]. Activation of the JAK/STAT signal transduction pathway promotes cell growth and cell cycle transformation [ 14 ].…”